Don’t Delay Bringing Up CML Concerns, a Doctor Says
To ensure best outcomes, patients with chronic myeloid leukemia should maintain frequent communication with their care teams — even between appointments.
Watch
Most Patients With CML Can Continue Their Normal Lifestyle During Treatment
Most — though not all — side effects from chronic myeloid leukemia treatment improve over time, an expert said.
Organizations Can Help Patients with CML Face the ‘Long Treatment Journey’
A chronic myeloid leukemia diagnosis can negatively affect patients and their loved ones’ mental health, but there are resources that can help.
Putting Quality of Life into Perspective During CML Treatment
Patients with chronic myeloid leukemia should be upfront with their care team about how treatment side effects are affecting their daily functioning.
Understanding the Disease, Treatments Help Patients Navigate a CML Diagnosis
Initial discussions about treatment, side effects and study results can help patients navigate through all aspects of a chronic myeloid leukemia diagnosis.
3 Questions to Ask Doctors After a CML Diagnosis
An advocate discusses vital patient-provider conversations to promote the best care for individuals with chronic myeloid leukemia.
Shared Decision-Making and Supportive Care in the CLL Treatment Journey
Clinical insights on shared decision-making practices and the importance of supportive care when treating patients with chronic lymphocytic leukemia.
Treatment Decisions in R/R CLL
A medical oncologist provides a comprehensive overview of treatment options for patients with relapsed/refractory chronic lymphocytic leukemia, including BTK inhibitors and CAR T-cell therapy.
Tumor Treating Fields for Brain Metastases in Lung Cancer Boost Quality of Life With Some Trade-Offs
For patients with non-small lung cancer and brain metastases, it’s important to consent to shaving the scalp before tumor-treating fields therapy.
Patients With Stage 3 Melanoma Should Discuss Adjuvant Therapy
Patients with resectable stage 3 melanoma should talk about pretreatment therapy with their cancer care teams, an expert said.
Trodelvy Improves Quality of Life Over Chemo in TNBC
Trodelvy led to better disease control and improved quality of life compared to chemotherapy in patients with triple-negative breast cancer.
An Overview of Potential Treatment Adverse Effects
An expert on chronic lymphocytic leukemia discusses adverse effects encountered by patients who are receiving BTK inhibitors or venetoclax-based regimens.
What to Know Before Starting Your CLL Treatment
Josie Montegaard, MSN, AGPCNP-BC, provides clinical insights on her approach to counseling patients who are receiving treatment for chronic lymphocytic leukemia.
Grief Advocate Explains the Difference Between Forced Joy and Toxic Positivity
After a cancer diagnosis, toxic positivity can be unhelpful, though forced joy may bring light to a difficult situation, a survivor and advocate said.
An Expert Breakdown of SurVaxM, the Novel Brain Cancer Vaccine
SurVaxM, which is being studied in gliobastoma, targets a certain protein that is found on the brain cancer cells.
Chemo, Targeted Drugs Extremely Efficacious in HER2-Positive Breast Cancer
Presurgical paclitaxel, Herceptin and Perjeta showed “incredible efficacy” in treatment of HER2-positive breast cancer.
Rybrevant Plus Leclaza Has ‘Very Potent Activity’ in Lung Cancer Subset
Rybrevant plus Leclaza had promising response and progression-free survival rates in patients with EGFR-mutant non-small cell lung cancer.
Newer Combinations for the Treatment of CLL
Dr Linhares discusses newer combination therapies for the treatment of patients with chronic lymphocytic leukemia, highlighting ibrutinib and venetoclax, which is being studied in the CAPTIVATE trial.
Ibrutinib-Based Treatment Clinical Trial Updates
Turning the focus to ibrutinib-based therapy, Yuliya Linhares, MD, gives an overview of the RESONATE study.
Zanubrutinib-Based Treatment Clinical Trial Updates
Expert perspectives on the SEQUOIA study, which is investigating zanubrutinib in patients with chronic lymphocytic leukemia.
Venetoclax-Based Treatment Clinical Trial Updates
Yuliya Linhares, MD, discusses the CLL14 study, which is looking at venetoclax plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia.
Acalabrutinib-Based Treatment Clinical Trial Updates
Focusing on acalabrutinib-based treatment, Yuliya Linhares, MD, discusses results from the ELEVATE TN clinical trial.
Overview of Efficacy and Safety Data for Current CLL Treatment Options
A general overview of efficacy and safety data for current treatment options for patients with chronic lymphocytic leukemia.
Breast Cancer Vaccines Could Possibly Make a Change for “So Many”
“I think there is a very near future where we have available breast cancer vaccines for all of us, our children and for everybody,” said Kristen Dahlgren.
Social Support Is Key During BiTE Therapy for Blood Cancers
An oncology nurse discusses what patients should know before BiTE therapy, and what they can do if they do not have a social support system.
What to Expect from Treatment
Josie Montegaard, MSN, AGPCNP-BC, offers expert perspectives on treatment considerations in CLL, focusing on BTK inhibitors and venetoclax-based therapy.
Factors That Guide CLL Treatment Decisions
Dr Linhares provides clinical insights on factors that guide treatment decisions for patients with chronic lymphocytic leukemia, such as comorbidities and disease biology.
Easing a Hospital Stay for a Patient With Cancer as an Oncology Nurse
Jessica McDade, B.S.N., RN, OCN, explains how she helps make her patients’ experience “a little less daunting” during their hospital stay.
Nurse Says CAR-T Cell Therapy is a ‘Mind-Blowing’ Advancement
For patients with blood cancers, CAR-T cell therapy has been a “mind-blowing” advancement for treatment in the cancer space.
Child-Focused Organizations Give Parents With Cancer ‘One Less Stress’
An oncology nurse explained the impacts that organizations like Wonders & Worries can make on children of patients with cancer.
